ACAD
47.38
-1.22
-2.51%
AEMD
9.5
-0.05
-0.52%
APRI
1.49
+0.00
+0.0134%
ARNA
3.915
-0.175
-4.279%
ATEC
1.36
0.00
0.00%
CNAT
4.94
+0.01
+0.20%
CRXM
0.3
0.00
0.00%
CYTX
0.432
-0.008
-1.7273%
DXCM
83.18
-0.38
-0.45%
GNMK
8.4
-0.35
-4.00%
HALO
22.75
-0.68
-2.90%
ILMN
217.71
+0.52
+0.24%
INNV
0.155
0.00
0.00%
INO
7.2
-0.2
-2.70%
ISCO
0.043
0.00
0.00%
ISIS
52.2
-0.85
-1.60%
LGND
105.67
-1.19
-1.11%
LPTN
0.27
-0.005
-1.8195%
MBVX
1.86
+0.06
+3.33%
MEIP
1.62
-0.03
-1.82%
MNOV
3.6
-0.27
-6.98%
MRTX
26.63
-0.83
-3.02%
MSTX
0.458
+0.003
+0.7486%
NBIX
48.84
-1.82
-3.59%
NUVA
54.99
+0.4
+0.73%
ONCS
6.18
+0.01
+0.16%
ONVO
3.4
-0.14
-3.95%
OREX
3.92
+0.01
+0.26%
OTIC
25.33
-0.78
-2.99%
QDEL
21.242
-0.228
-1.0601%
RCPT
227.24
-0.4
-0.18%
RGLS
8.155
-0.035
-0.427%
RMD
55.46
-0.46
-0.82%
SCIE
0.02
0.00
0.00%
SPHS
0.89
-0.01
-1.10%
SRNE
19.29
+0.09
+0.47%
TROV
7.64
-0.37
-4.62%
VICL
0.632
-0.006
-0.9400%
ZGNX
19.275
+0.785
+4.246%
ACAD
47.38
-1.22
-2.51%
AEMD
9.5
-0.05
-0.52%
APRI
1.49
+0.00
+0.0134%
ARNA
3.915
-0.175
-4.279%
ATEC
1.36
0.00
0.00%
CNAT
4.94
+0.01
+0.20%
CRXM
0.3
0.00
0.00%
CYTX
0.432
-0.008
-1.7273%
DXCM
83.18
-0.38
-0.45%
GNMK
8.4
-0.35
-4.00%
HALO
22.75
-0.68
-2.90%
ILMN
217.71
+0.52
+0.24%
INNV
0.155
0.00
0.00%
INO
7.2
-0.2
-2.70%
ISCO
0.043
0.00
0.00%
ISIS
52.2
-0.85
-1.60%
LGND
105.67
-1.19
-1.11%
LPTN
0.27
-0.005
-1.8195%
MBVX
1.86
+0.06
+3.33%
MEIP
1.62
-0.03
-1.82%
MNOV
3.6
-0.27
-6.98%
MRTX
26.63
-0.83
-3.02%
MSTX
0.458
+0.003
+0.7486%
NBIX
48.84
-1.82
-3.59%
NUVA
54.99
+0.4
+0.73%
ONCS
6.18
+0.01
+0.16%
ONVO
3.4
-0.14
-3.95%
OREX
3.92
+0.01
+0.26%
OTIC
25.33
-0.78
-2.99%
QDEL
21.242
-0.228
-1.0601%
RCPT
227.24
-0.4
-0.18%
RGLS
8.155
-0.035
-0.427%
RMD
55.46
-0.46
-0.82%
SCIE
0.02
0.00
0.00%
SPHS
0.89
-0.01
-1.10%
SRNE
19.29
+0.09
+0.47%
TROV
7.64
-0.37
-4.62%
VICL
0.632
-0.006
-0.9400%
ZGNX
19.275
+0.785
+4.246%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.